Balchem Corporation (BCPC)
NASDAQ: BCPC
· Real-Time Price · USD
165.24
1.24 (0.76%)
At close: May 08, 2025, 3:59 PM
165.18
-0.04%
Pre-market: May 09, 2025, 04:25 AM EDT
0.76% (1D)
| Bid | 162.34 |
| Market Cap | 5.39B |
| Revenue (ttm) | 964.54M |
| Net Income (ttm) | 136.54M |
| EPS (ttm) | 4.17 |
| PE Ratio (ttm) | 39.63 |
| Forward PE | 32.21 |
| Analyst | Buy |
| Ask | 166.16 |
| Volume | 89,599 |
| Avg. Volume (20D) | 189,436 |
| Open | 164.46 |
| Previous Close | 164.00 |
| Day's Range | 164.11 - 166.11 |
| 52-Week Range | 145.70 - 186.03 |
| Beta | 0.94 |
About BCPC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BCPC
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BCPC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
-2.6%
Balchem shares are trading lower. The company repo...
Unlock content with
Pro Subscription
6 months ago
+3.19%
Balchem shares are trading higher after the company reported better-than-expected Q3 adjusted EPS results.
2 months ago · seekingalpha.com
Balchem Is A Great Company, But I'm Still Waiting For A Better EntryBalchem Corporation specializes in performance ingredients across nutrition, food, pharmaceuticals, and animal health, but its high P/E ratio and rising costs warrant a "Hold" rating. Q4 2024 saw mode...
2 months ago · seekingalpha.com
Balchem Corporation (BCPC) Q4 2024 Earnings Conference Call TranscriptBalchem Corporation (NASDAQ:BCPC ) Q4 2024 Earnings Conference Call February 21, 2025 11:00 AM ET Company Participants Martin Bengtsson - CFO Ted Harris - Chairman, President and CEO Conference Call P...
